PMID- 10408803 OWN - NLM STAT- MEDLINE DCOM- 19990831 LR - 20190905 IS - 0198-8859 (Print) IS - 0198-8859 (Linking) VI - 60 IP - 6 DP - 1999 Jun TI - Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. PG - 532-8 AB - The impact of donor-recipient DPA1 and DPB1 matching was examined in 122 unrelated bone marrow transplant pairs. All pairs were serologically matched at the time of transplantation for HLA class I and II and a majority also DRB1 allele matched. Retrospective A, B, C, DRB1, DQA1, DQB1 in addition to DPA1 and DPB1 allele matching was performed by molecular techniques. The percentage of pairs that were allele matched was as follows; HLA-A = 91% (n = 80), HLA-B = 94% (n = 80), HLA-C = 78% (n = 80), HLA-DRB1 = 96% (n = 122), HLA-DQA1 = 99% (n = 80), HLA-DQB1 = 92% (n = 122). 92 recipient/donor pairs with informative clinical data were available for analysis. DPA1 identity (no incompatibility in either direction) was observed in 57% and DPA1 compatibility in 76% of pairs with no apparent beneficial effect of matching on patient survival or Graft Versus Host Disease (GVHD). DPB1 identity was observed in 11% and compatibility in 27% of pairs. A significant improvement in patient survival was observed in DPB1 matched compared to one DPB1 mismatch (p < 0.01) and combined one and two DPB1 mismatched transplants (p = 0.03). This beneficial effect remained when allele mismatches at HLA-A, B, C, DRB1, DQA1, DQB1 were excluded (p = 0.05, p = 0.03, respectively). There was a significant association of increased frequency of severe GVHD (grades III-IV) compared to mild GVHD (grades I-II) with DPB1 mismatched transplants compared to DPB1 matched transplants (p = 0.04). In DPB1 mismatched transplants an association between patient survival and matching for individual DPB1 polymorphic regions was not observed; however in the HLA-A, B, DRB1, DQA1, DQB1 allele matched transplants a non significant increase in the frequency of Grade IV GVHD was observed in recipients who were negative compared to those who were positive for DPB1 alleles coding for glutamic acid at position 69. FAU - Varney, M D AU - Varney MD AD - Department of Pathology, Royal Melbourne Hospital,Parkville, Vic, Australia. FAU - Lester, S AU - Lester S FAU - McCluskey, J AU - McCluskey J FAU - Gao, X AU - Gao X FAU - Tait, B D AU - Tait BD LA - eng PT - Journal Article PL - United States TA - Hum Immunol JT - Human immunology JID - 8010936 RN - 0 (HLA-DP Antigens) RN - 0 (HLA-DP alpha-Chains) RN - 0 (HLA-DP beta-Chains) RN - 0 (HLA-DPA1 antigen) RN - 0 (HLA-DPB1 antigen) SB - IM MH - Adult MH - *Alleles MH - Bone Marrow Transplantation/*immunology MH - Child MH - Follow-Up Studies MH - Graft Survival MH - Graft vs Host Disease MH - HLA-DP Antigens/*genetics MH - HLA-DP alpha-Chains MH - HLA-DP beta-Chains MH - Histocompatibility Testing MH - Humans MH - Prospective Studies MH - Retrospective Studies EDAT- 1999/07/17 00:00 MHDA- 1999/07/17 00:01 CRDT- 1999/07/17 00:00 PHST- 1999/07/17 00:00 [pubmed] PHST- 1999/07/17 00:01 [medline] PHST- 1999/07/17 00:00 [entrez] AID - S0198-8859(99)00004-X [pii] AID - 10.1016/s0198-8859(99)00004-x [doi] PST - ppublish SO - Hum Immunol. 1999 Jun;60(6):532-8. doi: 10.1016/s0198-8859(99)00004-x.